Table 3. Characteristics of methicillin-resistant Staphylococcus sciuri strains isolated from nasal and throat swab specimens obtained from hospitalised patients and healthcare workers (HCWs).
| MRSS isolate | P/HCW | Department | Pulsotype | mec class | ccr type | Resistance profile | Resistance gene detected in isolate | MIC of fusidic acid (mg/L) |
|---|---|---|---|---|---|---|---|---|
| 1 | P | ED | A | A | 3 | GEN, KAN, TOB, FA, ERY, CLI, CIP, RIF | aacA-aphD, aphA3, erm(C) | 16 |
| 2 | P | ED | B | A | 3 | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD | 4 |
| 3 | P | SD | B | A | 3 | GEN, KAN, TOB, CLI(i) | aacA-aphD | 1 |
| 4 | P | SD | B | A | 3 | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD | 4 |
| 5 | P | SD | B | A | 3 | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD | 4 |
| 6 | P | ED | C1 | A | NT | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD, aphA3, lnu(A) | 16 |
| 7 | HCW | ED | C2 | A | 3 | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD, aphA3, lnu(A) | 16 |
| 8 | P | SD | C3 | A | 3 | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD, aphA3, erm(C), lnu(A) | 16 |
| 9 | P | ED | D | A | NT | GEN, KAN, TOB, FA, CLI(i), CHL | aacA-aphD, cat2211 | 16 |
| 10 | P | SD | E | A | 3 | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD, aadC, lnu(A) | 8 |
| 11 | HCW | SD | E | A | 3 | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD, aadC, lnu(A) | 8 |
| 12 | P | ED | F | A | 3 | GEN, KAN, TOB, FA, CLI(i), CHL | aacA-aphD, aphA3, cat2211 | 8 |
| 13 | P | SD | F | A | 3 | GEN, KAN, TOB, FA, CLI(i), CHL | aacA-aphD, aphA3, cat2211 | 8 |
| 14 | P | SD | G | A | NT | GEN, KAN, TOB, FA, CLI(i) | aacA-aphD, aadC | 2 |
| 15 | HCW | ED | H | A | 3 + 5 | GEN, KAN, TOB, CLI(i), TET, CIP. CHL, RIF(i), MUP | aacA-aphD, aphA3, cat221, tet(M) | 16 |
| 16 | P | MD | I | A | NT | FA, CLI(i) | / | 8 |
1, PCR product had a higher molecular weight than the positive control; P, patient; HCW, healthcare worker; NT, not typeable; ED, Emergency Department; SD, Surgical Department; MD, Medical Department, GEN, gentamicin; KAN, kanamycin; TOB, tobramycin; FA, fusidic acid; ERY, erythromycin; CLI, clindamycin; CIP, ciprofloxacin; RIF, rifampicin; TET, tetracycline; CHL, chloramphenicol; MUP, mupirocin; (i), intermediate resistant; MIC, minimum inhibitory concentration.